Cite
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
MLA
Ra, Seung Won, et al. “Azithromycin and Risk of COPD Exacerbations in Patients with and without Helicobacter Pylori.” Respiratory Research, 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367421773&authtype=sso&custid=ns315887.
APA
Ra, S. W., Ra, S. W., Sze, M. A., Lee, E. C., Tam, S., Oh, Y., Fishbane, N., Criner, G. J., Woodruff, P. G., Lazarus, S. C., Albert, R., Connett, J. E., Han, M. K., Martinez, F. J., Aaron, S. D., Reed, R. M., Man, S. P., Sin, D. D., & Canadian Respiratory Research Network. (2017). Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. Respiratory Research.
Chicago
Ra, Seung Won, Seung Won Ra, Marc A Sze, Eun Chong Lee, Sheena Tam, Yeni Oh, Nick Fishbane, et al. 2017. “Azithromycin and Risk of COPD Exacerbations in Patients with and without Helicobacter Pylori.” Respiratory Research. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367421773&authtype=sso&custid=ns315887.